Caitong International Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Caitong International Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,021	Closed	-$53.8K	–	3439
2026 Q1	$53.8K	Buy	+1,021	New	+$41.9K	0.01%	762
2025 Q4	–	Sell	-651	Closed	-$4.89K	–	2362
2025 Q3	$4.89K	Buy	+651	New	+$4.16K	﹤0.01%	1232
2025 Q2	–	Sell	-531	Closed	-$1.47K	–	2478
2025 Q1	$1.47K	Buy	+531	New	+$2.17K	﹤0.01%	1452

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's TERN Position: Q2 2026 in Review

Caitong International Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,021 shares — an estimated $53.8K sold.

Caitong International Asset Management first reported a position in TERN in Q1 2025 and held it in 3 quarters. The position peaked at $53.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Caitong International Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 1,021 Terns Pharmaceuticals shares in Q2 2026, an estimated $53.8K.
Caitong International Asset Management first reported a position in Terns Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Caitong International Asset Management's Terns Pharmaceuticals position peaked at $53.8K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.